A U.S. Food and Drug Administration–pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma

Daniel Lee, Laleh Amiri‐Kordestani, Chana Weinstock et al.|European Urology|2023

Cited by 19